Global Cancer Stem Cell Therapeutics Market Size Hit USD 2,215.8 Million at a CAGR of 9.5% in 2030

Published March 28, 2023

The global cancer stem cell therapeutics market size was USD 971.1 Million in 2021 and is expected to register a revenue CAGR of 9.5% over the forecast period, according to the latest report by Reports and Data.

Recent years have seen rapid advancement in stem cell research as well as the therapeutic application of these helpful cells. To far, more than 1,000 clinical trials involving stem cells have been conducted worldwide. Additionally, more than 10 products made from stem cells have received approval in different nations. Some nations have tried to employ clinical trials as a means of slowing down the speed of stem cell use in clinics because the number of stem cell applications has expanded so quickly.

In the near future, it’s anticipated that stem cell therapy, also known as regenerative medicine, would drastically alter the healthcare system. As stem cells may give rise to a wide variety of cell types and divide mitotically, they are capable of self-renewal. In the upcoming years, stem cell therapy is anticipated to have a significant impact on the healthcare system. The market for cancer stem cell therapy is experiencing revenue growth due to both the growing demand for regenerative pharmaceuticals and the public’s growing understanding of the possibilities of stem cell treatment for disease management.

Companies profiled in the market report include AbbVie Inc., Aviva Systems Biology Corporation, Becton, Dickinson and Company (BD), Bionomics, Immunocellular Therapeutics, Ltd., Lonza Group AG, Merck KGaA, Novartis AG, Pfizer Inc., and STEMCELL Technologies Inc.

Get a sample of the report @

Market Overview:

The research report assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. The report estimates the market size, market growth, and provides an accurate forecast for the key segments of the market for the forecast period of 2022-2030. The report also covers an in-depth analysis of the key competitors of the market, along with their growth strategies and business expansion plans.

The Cancer Stem Cell Therapeutics Market has been segmented into key regions of the world and offers an analysis of growth rate, market share, market size, current and emerging trends, production and consumption ratio, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players in each region. A country-wise analysis of the market is offered in the report to gain a better understanding of the regional spread and progress of the Cancer Stem Cell Therapeutics Market.

Further key findings from the report suggest,

  • The market for cancer stem cell therapies has been divided into categories based on kind, including cell culturing, cell separation, cell analysis, molecular analysis, and others. Over the projected period, the cell culturing segment is anticipated to account for the biggest revenue share. Cancer stem cells have been shown to be essential for carcinogenesis processes like tumour growth, dissemination, and recurrence. To simulate the in vivo environment for cancer stem cells outside the body, numerous three-dimensional (3D) cell culture models have been developed. The signalling pathway patterns, gene function, cell-matrix and cell-cell interactions, and treatment resistance of cancer stem cells expanding in 3D culture systems reflect some of the tumour features seen in vivo.
  • In terms of revenue share, North America’s market dominated in 2021. North America has a highly developed healthcare system and infrastructure for medical research. With a sizable budget, the United States is a top hub for creative cancer stem cell research and development. The region’s biomedical market is anticipated to rise in terms of revenue due to the presence of numerous reputable biomedical research institutes and their involvement in the development of novel treatments and organ transplants. The presence of cutting-edge research infrastructure, involvement by numerous important medical institutions, growth in R&D initiatives to develop potential treatments for chronic conditions, and ease with which clinical testing approval can be granted are all anticipated to support the market’s revenue growth in the area.
  • A research cooperation and licence agreement to create and market up to four modified natural killer cell (iNK) and/or T cell (iT) therapies for solid tumours and hematologic malignancies was announced by Century Therapeutics and Bristol-Myers Squibb on January 10, 2022.

To understand how our Cancer Stem Cell Therapeutics Market can bring difference to your business strategy:

For the purpose of this report, Reports and Data has segmented the global cancer stem cell therapeutics industry into Type Outlook, Cancer Type Outlook, Application Outlook, Regional Outlook:

Type Outlook (Revenue, USD Billion; 2019-2030)

  • Cell Culturing
  • Cell Separation
  • Cell Analysis
  • Molecular Analysis
  • Others

Cancer Type Outlook (Revenue, USD Billion; 2019-2030)

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Others Cancer

Application Outlook (Revenue, USD Billion; 2019-2030)

  • Stem Cell-Based Cancer Therapy
  • Targeted CSC

Regional Outlook (Revenue, USD Billion; 2019-2030)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Request a customization of the report :

 Key Advantages of Cancer Stem Cell Therapeutics Market Report:

  • Identification and analysis of the market size and competition
  • Qualitative and quantitative analysis of the market data
  • Data validated by industry experts after extensive primary and secondary research
  • Extensive regional analysis of the Cancer Stem Cell Therapeutics industry
  • Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
  • SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
  • Feasibility analysis and investment analysis to enable strategic investment decisions
  • Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Conclusively, all aspects of the Cancer Stem Cell Therapeutics Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W
Head of Business Development
Direct Line: +1-212-710-1370
Reports and Data | Web:
Check our upcoming research reports @
Visit our blog for more industry updates @

Image Credit

Browse More Reports :


The post Global Cancer Stem Cell Therapeutics Market Size Hit USD 2,215.8 Million at a CAGR of 9.5% in 2030 appeared first on Market O Graphics.

Reports and Data